Industry News
No improvement seen in HIV-associated lymphoma survival during the antiretroviral therapy era
Jul 30, 2013
Stable survival rates were observed for HIV-associated lymphoma patients during the antiretroviral therapy (ART) era in the US, according to a new study published in the Journal of the National Cancer Institute... Read More
Treatments for tuberculosis, cancer will likely improve following breakthrough in detecting DNA mutations
Jul 30, 2013
The slightest variation in a sequence of DNA can have profound effects. Modern genomics has shown that just one mutation can be the difference between successfully treating a disease and having it spread rampantly throughout the body... Read More
New drug targets discovered for aggressive breast cancer
Jul 30, 2013
Scientists at A*STAR's Genome Institute of Singapore (GIS) led in a study that has identified genes that are potential targets for therapeutic drugs against aggressive breast cancer. These findings were reported in the July 2013 issue of PNAS. Out of the 1.5 million women diagnosed with breast cancer in the world annually, nearly one in seven of these is classified as triple negative... Read More
High platelet reactivity on clopidogrel predicts stent thrombosis, heart attack, and bleeding
Jul 30, 2013
Patients who receive a drug-eluting stent (DES) and demonstrate high platelet reactivity on clopidogrel are more likely to have blood clots form on the stent and to suffer a heart attack; however, these patients are less likely to develop bleeding complications. One-year results of the ADAPT-DES trial was published online in The Lancet... Read More
Screening asymptomatic high-risk adults for lung cancer may reduce deaths
Jul 29, 2013
A systematic review of the evidence suggests that screening asymptomatic high-risk adults at risk for lung cancer using low-dose computed tomography (LDCT) may reduce mortality. Lung cancer is the third most common cancer in the United States and is the leading cause of cancer-related death for both men and women... Read More
Print and web-based decision aids associated with increase in informed decision making about prostate cancer screening, study suggests
Jul 29, 2013
Both web-based and print-based decision aids appear to improve patients' informed decision making about prostate cancer screening up to 13 months later, but does not appear to affect actual screening rates, according to a study by Kathryn L. Taylor, Ph.D., of Georgetown University, Washington, D.C., and colleagues... Read More
Adaptimmune announces opening of Phase I/IIa clinical trial in ovarian cancer
Jul 29, 2013
Adaptimmune has announced that it has opened a Phase I/IIa, multiple-site, two-cohort, open-label clinical trial in ovarian cancer at Roswell Park Cancer Institute (RPCI) in Buffalo, N.Y., and City of Hope (COH) in Duarte, Calif... Read More
Adaptimmune announces opening of Phase I/IIa clinical trial in ovarian cancer
Jul 29, 2013
Adaptimmune has announced that it has opened a Phase I/IIa, multiple-site, two-cohort, open-label clinical trial in ovarian cancer at Roswell Park Cancer Institute (RPCI) in Buffalo, N.Y., and City of Hope (COH) in Duarte, Calif... Read More
Doctors pioneer use of 'bug' device to protect critically ill patients
Jul 29, 2013
Doctors in Southampton are the first in the world to fit critically ill patients with a revolutionary bug-like device to detect dangerous blood sugar levels... Read More
EGFR mutation testing dropped substantially once funding from the pharmaceutical industry was discontinued
Jul 29, 2013
Significant advances have taken place in the management of patients with advanced and metastatic non-small-cell lung cancer (NSCLC) over the last 5 years. Traditionally, all advanced NSCLC patients were treated in a similar manner. More recently, the importance of pathologic subtype has been recognized... Read More
Previous Page Next Page